Baroni, IT

Alfredo Baroni, Livorno IT

Patent application number	Description	Published
20150196129	WELLNESS CENTER STRUCTURE OF SMALL SIZE - A structure of wellness center comprises a support structure arranged to support a main bed at a first predetermined height from a floor of the room in which the structure same can be installed. The support structure has supporting side walls defining a wellness area, or grotto. Under the main bed, the wellness grotto has an entry through which a user can pass. Furthermore, a secondary bed is provided housed within the wellness area, or grotto, under said main bed at a second height from the floor of a room, with h2	07-16-2015

Domenico Baroni, Torino (to) IT

Patent application number	Description	Published
20110190445	INHIBITION OF HRP-3 USING MODIFIED OLIGONUCLEOTIDES - The present invention refers to agents for modulating the activity of proteins having a PWWP domain.	08-04-2011

Guido Baroni, Monza (milano) IT

Patent application number	Description	Published
20080300681	BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS - A tissue expansion device implanted in a non-activated state over a region of desired tissue growth. Once implanted and positioned the device is activated creating a supporting structure that creates a convex shaped dome over the underlying tissue. The convex shaped dome formed by the tissue expansion device places a tensile stress against the underlying tissue that promotes tissue growth. Alone or with the introduction of tissue enhancing agents and/or adipose tissue, new tissue within the convex shaped void grows until a balance is achieved eliminating the induced stress. Periodically the tissue expansion devices is again activated and enlarged creating an even larger void. Again, the newly enlarged void places additional tensile stress on the underlying tissue thus repeating the cycle of new tissue growth. Once the desired amount of tissue growth has been achieved the device is deactivated and removed.	12-04-2008
20090181104	BREAST RECONSTRUCTION OR AUGMENTATION USING COMPUTER-MODELED DEPOSITION OF PROCESSED ADIPOSE TISSUE - A tissue transfer method for reconstruction and augmentation of soft tissue. The method includes harvesting adipose tissue from a patient. The harvested tissue is processed via centrifugation to isolate a purified subset of the adipose tissue including separating and removing a substantial amount of triglycerides from the harvested adipose tissue. The centrifugation may be performed to cause separation of water from the purified adipose tissue and to cause separation of oil from mature adipocytes. Specifically, the spin rates may be selected to be high enough to cause lesions in the mature adipocytes that results in the release of the oil. The method continues with implanting the purified adipose tissue into the patient at a breast or other area identified for reconstruction or augmentation. The implanting is performed based on an injection pathway model that defines injection point locations and a number of injection pathway directions from each point.	07-16-2009

Guido Baroni, Milano IT

Patent application number	Description	Published
20150174341	INSTRUMENT FOR THE DEPOSITION OF ADIPOSE TISSUE IN LIPOMODELLING - A device for the deposition of adipose tissue, comprising: a) a syringe for grafting the tissue, b) a system for controlling the advance of the plunger of the syringe, which receives information about the movement of the syringe in the direction of withdrawal from an external system for detecting the movement of the syringe, and c) an external system for detecting the movement of the syringe. The control system determines the advance of the plunger of the syringe on the basis of the movement of the syringe in the direction of withdrawal and on the basis of the quantity of adipose tissue per unit of length of deposition. The advantages deriving from the use of this device in lipomodelling (or fat grafting) are in an automatic control of deposition of the adipose tissue and a correct uniformity of the graft.	06-25-2015

Guido Baroni, Monza (mb) IT

Patent application number	Description	Published
20140300867	DEVICE FOR MONITORING POSITION AND MOVEMENTS OF AN EYE, PARTICULARLY SUITABLE FOR OCULAR RADIOTHERAPY - A device for non-invasive monitoring of an eye position and ocular movements of a patient having: a housing body (	10-09-2014

Guido Baroni, Monza IT

Patent application number	Description	Published
20100160948	BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS - A tissue expansion device implanted in a non-activated state over a region of desired tissue growth. Once implanted and positioned the device is activated creating a supporting structure that creates a convex shaped dome over the underlying tissue. The convex shaped dome formed by the tissue expansion device places a tensile stress against the underlying tissue that promotes tissue growth. Alone or with the introduction of tissue enhancing agents and/or adipose tissue, new tissue within the convex shaped void grows until a balance is achieved eliminating the induced stress. Periodically the tissue expansion devices is again activated and enlarged creating an even larger void. Again, the newly enlarged void places additional tensile stress on the underlying tissue thus repeating the cycle of new tissue growth. Once the desired amount of tissue growth has been achieved the device is deactivated and removed.	06-24-2010
20100161052	BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS - A tissue expansion device implanted in a non-activated state over a region of desired tissue growth. Once implanted and positioned the device is activated creating a supporting structure that creates a convex shaped dome over the underlying tissue. The convex shaped dome formed by the tissue expansion device places a tensile stress against the underlying tissue that promotes tissue growth. Alone or with the introduction of tissue enhancing agents and/or adipose tissue, new tissue within the convex shaped void grows until a balance is achieved eliminating the induced stress. Periodically the tissue expansion devices is again activated and enlarged creating an even larger void. Again, the newly enlarged void places additional tensile stress on the underlying tissue thus repeating the cycle of new tissue growth. Once the desired amount of tissue growth has been achieved the device is deactivated and removed.	06-24-2010
20100168780	BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS - A tissue expansion device implanted in a non-activated state over a region of desired tissue growth. Once implanted and positioned the device is activated creating a supporting structure that creates a convex shaped dome over the underlying tissue. The convex shaped dome formed by the tissue expansion device places a tensile stress against the underlying tissue that promotes tissue growth. Alone or with the introduction of tissue enhancing agents and/or adipose tissue, new tissue within the convex shaped void grows until a balance is achieved eliminating the induced stress. Periodically the tissue expansion devices is again activated and enlarged creating an even larger void. Again, the newly enlarged void places additional tensile stress on the underlying tissue thus repeating the cycle of new tissue growth. Once the desired amount of tissue growth has been achieved the device is deactivated and removed.	07-01-2010
20110317890	SYSTEM AND METHOD FOR ADVANCED SCANNING AND FOR DEFORMATION SIMULATION OF SURFACES - A system and method for advanced scanning and for simulation of the deformation of surfaces are particularly advantageous for the application of three-dimensional scanning in the medical field. The system and the method allow obtaining digital models of surfaces characterized by an elevated signal-to-noise ratio and by the absence of artefacts due to the movements of the subject during the timing of the scanning. In particular, therefore, the method and system allow obtaining digital models of the surface of particular anatomical areas adapted for the pre-surgery planning, for the estimation and the evaluation of the surgical outcome and for the simulation of the deformation of the bodily surfaces due to predetermined movements performed by the subject.	12-29-2011
20130131655	BREAST RECONSTRUCTION OR AUGMENTATION USING COMPUTER-MODELED DEPOSITION OF PROCESSED ADIPOSE TISSUE - A tissue transfer method for reconstruction and augmentation of soft tissue. The method includes harvesting adipose tissue from a patient. The harvested tissue is processed via centrifugation to isolate a purified subset of the adipose tissue including separating and removing a substantial amount of triglycerides from the harvested adipose tissue. The centrifugation may be performed to cause separation of water from the purified adipose tissue and to cause separation of oil from mature adipocytes. Specifically, the spin rates may be selected to be high enough to cause lesions in the mature adipocytes that results in the release of the oil. The method continues with implanting the purified adipose tissue into the patient at a breast or other area identified for reconstruction or augmentation. The implanting is performed based on an injection pathway model that defines injection point locations and a number of injection pathway directions from each point.	05-23-2013

Guido Baroni, Monsa IT

Patent application number	Description	Published
20130046383	METHOD AND DEVICES FOR TISSUE EXPANSION - A device for maintaining or achieving soft tissue expansion applicable to any body region already temporarily expanded including: an adhesive element deformable and capable of adapting to the shape of this body region, and which can then itself become mechanically rigid enough to resist tendency of the expanded tissue to recoil or to which a second material can be applied to form a stent adapted to the shape of the body area to provide the necessary structural rigidity to prevent recoil of the expansion and thereby induce its retention of its expanded shape after the stent is removed.	02-21-2013
20140288646	METHOD AND DEVICES FOR TISSUE EXPANSION - A device for maintaining or achieving soft tissue expansion applicable to any body region already temporarily expanded including: an adhesive element deformable and capable of adapting to the shape of this body region, and which can then itself become mechanically rigid enough to resist tendency of the expanded tissue to recoil or to which a second material can be applied to form a stent adapted to the shape of the body area to provide the necessary structural rigidity to prevent recoil of the expansion and thereby induce its retention of its expanded shape after the stent is removed.	09-25-2014
20160000551	METHOD AND DEVICES FOR TISSUE EXPANSION - A device for maintaining or achieving soft tissue expansion applicable to any body region already temporarily expanded including: an adhesive element deformable and capable of adapting to the shape of this body region, and which can then itself become mechanically rigid enough to resist tendency of the expanded tissue to recoil or to which a second material can be applied to form a stent adapted to the shape of the body area to provide the necessary structural rigidity to prevent recoil of the expansion and thereby induce its retention of its expanded shape after the stent is removed.	01-07-2016

Marco Baroni, Barbasso Di Roncoferraro (mantova) IT

Patent application number	Description	Published
20110041456	ROTARY CONVEYOR COMPRISING A GRIPPER MECHANISM - The components of a rotary conveyor (	02-24-2011
20110120055	ENCLOSING STRUCTURE FOR CONTAINER PACKAGING MACHINES AND/OR MACHINE UNITS, IN PARTICULAR CAPPING MACHINES - A packaging machine or machine unit, as used in particular for capping containers (	05-26-2011

Marco Baroni, Vanzago IT

Patent application number	Description	Published
20140296513	NOVEL THERAPEUTIC USE OF P75 RECEPTOR ANTAGONISTS - The present disclosure relates to the use of a p75 receptor antagonist or its pharmaceutically acceptable salts for the preparation of a medicament for use in the treatment and/or prevention of overactive bladder.	10-02-2014

Marco Baroni, Vanzago-Milano IT

Patent application number	Description	Published
20110144120	PHENYL-ALKYL PIPERAZINES HAVING TNF-MODULATING ACTIVITY, PREPARATION METHOD, AND THERAPEUTIC USE THEREOF - The present invention relates to phenyl-alkyl piperazines of formula (I):	06-16-2011
20110144122	DERIVATIVES OF 2-OXOALKYL-1-PIPERAZIN-2-ONE, PREPARATION METHOD THEREOF AND THERAPEUTIC USE OF SAME - The present invention relates to derivatives of 4-{2-[phenyl-3,6-dihydropyridin-1-yl]-2-oxoalkyl}-1-piperazin-2-one and 4-{2-[phenyl-2,5-dihydropyrrol-1-yl]-2-oxoalkyl}-1-piperazin-2-one having general formula (I):	06-16-2011
20120245149	NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS - The disclosure relates to (heterocycle-fused piperidine)-(piperazinyl)-1-alkanone derivatives and (heterocycle-fused pyrrolidine)-(piperazinyI)-1-alkanone derivatives of formula (I):	09-27-2012
20120245150	NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS - The disclosure relates to (heterocycle-tetrahydropyridine)(piperazinyl)-1-alkanone and (heterocycle-dihydropyrrolidine)(piperazinyl)-1-alkanone derivatives of formula (I):	09-27-2012
20120289518	DERIVATIVES OF 2-OXOALKYL-1-PIPERAZIN-2-ONE, PREPARATION METHOD THEREOF AND THERAPEUTIC USE OF SAME - The present invention relates to derivatives of 4-{2-[phenyl-3,6-dihydropyridin-1-yl]-2-oxoalkyl}-1-piperazin-2-one and 4-{2-[phenyl-2,5-dihydropyrrol-1-yl]-2-oxoalkyl}-1-piperazin-2-one having general formula (I):	11-15-2012
20130303520	NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS - The disclosure relates to (heterocycle-tetrahydropyridine)(piperazinyl)-1-alkanone and (heterocycle-dihydropyrrolidine)(piperazinyl)-1-alkanone derivatives of formula (I):	11-14-2013
20140038946	NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS - The disclosure relates to (heterocycle-fused piperidine)-(piperazinyl)-1-alkanone derivatives and (heterocycle-fused pyrrolidine)-(piperazinyl)-1-alkanone derivatives of formula (I):	02-06-2014

Marco Baroni, Milano IT

Patent application number	Description	Published
20100210662	INDOL-2-ONE DERIVATIVES DISUBSTITUTED IN THE 3-POSITION, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF - The present invention relates to 3-disubstituted indol-2-one derivatives, to their preparation and to their therapeutic application.	08-19-2010
20110118280	INDOL-2-ONE DERIVATIVES DISUBSTITUTED IN THE 3-POSITION, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF - The present invention relates to 3-disubstituted indol-2-one derivatives, to their preparation and to their therapeutic application.	05-19-2011
20110144116	DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS - The present invention relates to derivatives of ((phenyl)-3,6-dihydropyridin-1-yl)(bridged piperazinyl)-1-alkanone derivatives and ((phenyl)-2,5-dihydropyrrol-1-yl) (bridged piperazinyl)-1-alkanone corresponding to Formula (I):	06-16-2011
20120232280	DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS - The present invention relates to derivatives of ((phenyl)-3,6-dihydropyridin-1-yl)(bridged piperazinyl)-1-alkanone derivatives and ((phenyl)-2,5-dihydropyrrol-1-yl) (bridged piperazinyl)-1-alkanone corresponding to Formula (I):	09-13-2012

Maria Cristina Baroni, Parma IT

Patent application number	Description	Published
20160083427	CYCLIC CATIONIC PEPTIDES WITH ANTIBMICROBIAL ACTIVITY - A series of cationic cyclic peptides, useful for the treatment of infectious diseases in both human and veterinary clinical/surgical environment are described herein. The peptides of the invention have a length of 15 to 21 amino acids, and show a sequence A-B-C-D-C′-B′-A′, wherein units A and A′ correspond to —NH	03-24-2016

Massimo Baroni, Castellarano(re) IT

Patent application number	Description	Published
20110077829	CONTROL OF A CONTINUOUSLY VARIABLE TRANSMISSION - A method is described for operating a vehicle fitted with a continuously variable transmission (CVT) and having a lever for varying the transmission ratio of the CVT to permit the vehicle operator to vary the vehicle wheel speed. In the invention, the transmission ratio of the CVT is limited to a value dependent upon at least one of the prevailing engine speed and the rate of change of the engine speed.	03-31-2011

Massimo Baroni, Castellarano (re) IT

Patent application number	Description	Published
20100216595	System and Method for Controlling the Torque Transferable by a Mechanical Drive Employing an Oil-Bath Clutch - A system and method for controlling the torque transferable by a mechanical drive between an engine and a shaft of a vehicle includes a first actuator which acts on a variable-speed drive, a second actuator which acts on a clutch to determine the degree of engagement/release of the clutch; and a measuring device for measuring the torque to or from the variable-speed drive. The first and second actuators and the measuring device are controlled by an electronic central control unit to protect the variable-speed drive and/or the clutch from mechanical overloading of the mechanical drive.	08-26-2010

Massimo Baroni, Castellarano IT

Patent application number	Description	Published
20140297158	ENGINE CONTROL DEVICE FOR A WORK VEHICLE - An engine control device for a vehicle is provided, which comprises a control unit configured to be connected to the engine of a vehicle and to control the switching of the engine from a first idle rotation speed to a second idle rotation speed in which the number of engine revolutions is lower compared to the number of revolutions of the first idle speed. The control device also includes a first sensor, configured to be connected to the engine and to instantaneously sense and transmit to the control unit the number of revolutions completed by the engine in the unit of time. The control device further includes a second sensor for detecting the presence of an operator at the vehicle controls, and the second sensor is configured to transmit to the control unit a signal indicating the presence of an operator at the vehicle controls. The control unit is configured to actuate a decrease in the engine rotation speed from the first idle speed toward the second idle speed if the signal transmitted by the second sensor indicates the operator's absence and the signal transmitted by the first sensor indicates that the engine is running at the first idle speed.	10-02-2014

Maurizio Baroni, Chiari IT

Patent application number	Description	Published
20080258419	Suspension for a wheel of a motor-vehicle, in particular a bus - In a suspension for a wheel of a motor-vehicle, supporting, through a corresponding articulated spindle, V-shape arms, receiving a spring forming resilient cushioning element thereon the motor vehicle body bears, the resilient cushioning element comprises a base bearing on parallel guides of the V-shape arms, thereby forming a bearing surface, the central guide including a hole for receiving a throughgoing clamping screw for clamping the resilient cushioning element at a target position.	10-23-2008

Pablo Baroni, Vicopisano IT

Patent application number	Description	Published
20160067936	MACHINE AND METHOD FOR FORMING BOXES OF PAPER OR CARDBOARD - A quadrangular machine for forming boxes (	03-10-2016

Paolo Baroni, Gattinara IT

Patent application number	Description	Published
20110110388	METHOD AND APPARATUS FOR REDUCING THE AMPLITUDE MODULATION OF OPTICAL SIGNALS IN EXTERNAL CAVITY LASERS - The present invention concerns a laser apparatus (	05-12-2011
20130308664	Method and Apparatus for Reducing the Amplitude Modulation of Optical Signals in External Cavity Lasers - A laser apparatus includes an external cavity laser (ECL) where the optical signal is modulated by an electrical modulation signal for modulating in frequency the laser output signal. The modulation in frequency produces a modulation of intensity (power) of the laser output signal, also denoted amplitude modulation (AM). A method of controlling the AM amplitude of a signal emitted by an ECL includes a gain medium, a phase element with variable transmissivity induced by the modulation, and a spectrally selective optical filter that selects and keeps the AM amplitude below a certain desired value or minimizes such value. A control method and a laser apparatus are also described in which the reduction of the AM component of the output power is achieved by acting on the gain of the gain medium of the ECL.	11-21-2013

Sergio Baroni, Milano IT

Patent application number	Description	Published
20130231291	FERMENTED SOYA BASED MIXTURE COMPRISING ISOFLAVONES- AGLICONES, EQUOL AND LUNASIL, PROCESS FOR THE PREPARATION AND USES THEREOF IN FOOD, MEDICAL AND COSMETIC FIELDS - The present invention concerns a mixture comprising isoflavones-aglicones, such as daidzein, genistein and glycitein, in addition to equol and lunasin, said mixture being based on soya fermented using lactic acid bacteria isolated from food matrices and use of said mixture for protection of skin and similar and of human intestinal cells with particular reference to prevention of inflammatory state and protection of barrier functions and hair loss treatment.	09-05-2013

Sergio Baroni, Bergamo IT

Patent application number	Description	Published
20100305077	COMPOUNDS FOR THE SELECTIVE TREATMENT OF THE INTESTINAL IMMUNO-INFLAMMATORY COMPONENT OF THE CELIAC DISEASE - In one aspect, the present invention relates to amino-salicylic-aminophenylpropionic compounds for the use in the treatment of the inflammatory component of the celiac disease. These compounds act by blocking the cytokines released in the celiac disease and are specifically useful in the treatment of cases refractory to the diet, in dietary errors and in the reduction of the celiac disease remission time.	12-02-2010
20120157417	COMPOUNDS FOR THE SELECTIVE TREATMENT OF THE INTESTINAL IMMUNO-INFLAMMATORY COMPONENT OF THE CELIAC DISEASE - In one aspect, the present invention relates to amino-salicylic—aminophenylpropionic compounds for the use in the treatment of the inflammatory component of the celiac disease. These compounds act by blocking the cytokines released in the celiac disease and are specifically useful in the treatment of cases refractory to the diet, in dietary errors and in the reduction of the celiac disease remission time.	06-21-2012

Sergio Baroni, Villa D' Adda IT

Patent application number	Description	Published
20090258837	Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation - The invention relates to analogous compounds of 6-thioguanosine triphosphate of general formula (I). A compound of the general formula (I); wherein the dashed bond in the sugar moiety can be either single or double and wherein R1, R2, R3, R4 or R5, equal or different between each other, have general formula -(Int)	10-15-2009
20100323980	Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation - The invention relates to analogous compounds of 6-thioguanosine triphosphate of general formula (I). A compound of the general formula (I); wherein the dashed bond in the sugar moiety can be either single or double and wherein R1, R2, R3, R4 or R5, equal or different between each other, have general formula -(Int)	12-23-2010
20110218164	THERAPEUTIC, DIETARY OR COSMETIC USE OF COMPOUNDS WITH SPECIFIC ANTI-APOPTOTIC ACTIVITY TOWARD CASPASE-3, AND COMPOSITIONS CONTAINING THESE COMPOUNDS - This invention regards the use of zeaxanthin and/or rutin, as such or further combined with spermidine, as the active principle in a pharmaceutical, dietary, or cosmetic composition, acting to inhibit caspase-3 and therefore to control apoptosis by preventing programmed cell death.	09-08-2011
20110224298	DIENE COMPOUNDS FOR USE IN HUMAN EPIDERMAL CELL REPAIR AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM - The present invention relates to a novel use of compounds having the general formula (I):	09-15-2011

Sergio Baroni, Villa D'Adda IT

Patent application number	Description	Published
20090048343	Compounds and Their Salts Specific to the PPAR Receptors and the EGF Receptors and Their Use in the Medical Field - The present invention relates to compounds comprising the general formula (I), in which R	02-19-2009
20090118357	Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field - Therefore the present invention relates specifically to the compounds of general formula (I), in which R	05-07-2009
20110039808	Multitarget Compounds Active at a PPAR and Cannabinoid Receptor - There is a need for pharmaceutical compounds which have activity at, at least one of a PPAR and a cannabinoid receptor. Thus there are provided such compounds, wherein the compound comprises: a PPAR pharmacophore and a cannabinoid pharmacophore linked together by a moiety comprising a fused bicyclic ring comprising a five membered ring fused with a six membered ring or a six membered ring fused with a six membered ring; wherein the cannabinoid pharmacophore comprises the fused bicyclic ring; and the PPAR pharmacophore comprises a salicylic acid, alkoxybenzylacetic acid or a alkoxyphenylacetic acid functionality; and wherein the PPAR pharmacophore is linked to the bicyclic ring of the cannabinoid pharmacophore through a linker comprising an amine or an amide functional group.	02-17-2011
20110218245	USE OF COMPOUNDS TO INHIBIT 5A-REDUCTASE ENZYME ACTIVITY, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM - The object of the present invention is the use of compounds designed to inhibit the activity of the enzyme 5α-reductase. This is a novel use of compounds of general formula (I):	09-08-2011
20120121705	Pharmaceutical Or Cosmetic Or Dietetic Composition Suitable For Promoting A Hair Pigmentation Effect - The invention relates to the use of spermidine or a pharmaceutically acceptable derivative thereof as the active principle in a pharmaceutical, cosmetic or dietetic composition. The composition is used for promoting pigmentation of the hair, particularly the shaft of the hair. The invention also relates to the composition which promotes this pigmentation effect, the composition containing spermidine or a derivative thereof (such as a salt) as an active principle and is intended for topical or oral administration.	05-17-2012
20120316230	Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field - The present invention relates to compounds of formula (I), where R	12-13-2012
20130005813	Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field - The present invention relates to compounds comprising the general formula (I), in which R	01-03-2013
20130102712	ADDUCTS WITH PERFLUOROPOLYETHER PHOSPHATE AND USES THEREOF - The present invention relates, in one aspect, to an adduct of formula O-PF-A, in which O is an oil; PF is a perfluoropolyether phosphate (PFPE phosphate); A is at least one substance selected from: (X) a water-soluble polyhydroxylated substance and (Y) a water-insoluble inorganic substance and to topical applications thereof in particular in the cosmetic and pharmaceutical field.	04-25-2013
20130121916	Compositions for Colon Lavage and Methods of Making and Using Same - Disclosed herein are compositions that include polyethylene glycol; alkali metal sulfate; electrolytes selected from the group consisting of sodium bicarbonate, sodium chloride, and potassium chloride or a mixture thereof; and a gastro-protected dye composition comprising a gastro-protectant and a dye suitable for use in an internal colon examination procedure. Also provided herein are sachets, and containers, e.g. sachets that include disclosed compositions; kits for colon cleansing, and aqueous solutions suitable for colon cleansing.	05-16-2013
20130150443	DIENE COMPOUNDS FOR USE IN HUMAN EPIDERMAL CELL REPAIR, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM - The present invention relates to a novel use of compounds having the general formula (I):	06-13-2013
20140030207	SYSTEM FOR PROLONGED RELEASE OF COSMETIC AGENTS - The present invention relates to a system for the release of cosmetic agents comprising at least one phospholipid, hyaluronic acid or derivatives thereof and a cationic polyurethane derivative. The system of the invention may be used in the formulation of cosmetic preparations for obtaining the protracted release of cosmetic agents or active substances to the epidermis or the keratinic structures of the human body, with a simultaneous reduction in the frequency of application.	01-30-2014
20150045436	Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field - The present invention relates to compounds comprising the general formula (I), in which R	02-12-2015
20150051285	Alkylamido Compounds and Uses Thereof - Disclosed herein are compounds that may be specific to PPAR and/or EGF receptors, and methods of making and using same.	02-19-2015
20150087678	METHODS OF TREATING LACTOSE INTOLERANCE - Disclosed herein are methods for treating lactose intolerance, including compounds that may be specific or modulate PPARγ receptors.	03-26-2015
20150087708	METHODS OF TREATING FIBROSIS - The present disclosure is directed in part to methods of treating fibrosis, e.g., hepatic fibrosis and/or intestinal fibrosis, comprising administering to a patient in need thereof an effective amount of a disclosed compound.	03-26-2015
20150148418	Methods of Treating Hair Related Conditions - Disclosed herein are methods for treating hair related disorders, including compounds that may be specific or modulate PPAR receptors.	05-28-2015
20150202132	PHARMACEUTICAL OR COSMETIC COMPOSITION FOR TREATING ALOPECIA - The present invention relates to a cosmetic or pharmaceutical composition for treating alopecia, and in general for counteracting excessive hair loss, comprising as an active ingredient a compound of formula (I) R—N	07-23-2015
20150250749	METHODS OF TREATING HAIR RELATED CONDITIONS - Provided herein are methods for enhancing epidermal regeneration in a patient in need thereof, comprising topically administering to said patient a pharmaceutically acceptable composition comprising N-acetyl-3-(4-aminophenyl)-2-methoxypropionic acid or a pharmaceutically acceptable salt or stereoisomer thereof, and a pharmaceutically acceptable excipient. For example, provided are methods for treating or ameliorating cicatricial alopecia, comprising topically administering to a patient in need thereof a pharmaceutically acceptable composition comprising the disclosed compounds. Also provided are methods for protecting hair follicle progenitor cells and compositions comprising same using the disclosed compounds.	09-10-2015
20150265514	METHODS OF INHIBITING HAIR GROWTH - Provided herein are methods for reducing mammalian hair growth using the disclosed compounds. Also provided herein are methods of inhibiting hair growth after hair removal of an area of mammalian skin of a mammal using the disclosed compounds.	09-24-2015
20150265562	Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field - The present invention relates to compounds comprising the general formula (I), in which R	09-24-2015
20150265563	Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field - The present invention relates to compounds comprising the general formula (I), in which R	09-24-2015
20150366770	COMPOSITION FOR COSMETIC USE SUITABLE TO PRODUCE A PIGMENTATION EFFECT ON HAIR - The invention concerns the use of compounds with formula (I) R—N1-spermidine, or 1,4-butandiamin,N-(3-amino propyl)-N1-R, (I) H	12-24-2015
20160030365	PHARMACEUTICAL OR COSMETIC COMPOSITION SUITABLE TO PRESERVE EPITHELIAL STEM CELLS - The invention concerns the use of compounds of formula (I) R-N	02-04-2016
20160030500	FLAVONOID-BASED COMPOSITION FOR PHARMACEUTICAL, NUTRITIONAL OR COSMETIC USE HAVING POTENTIATED ANTIOXIDANT ACTION - The invention relates to a composition for pharmaceutical or nutritional or cosmetic use, formulated for oral or topical use and possessing antioxidant activity against free radicals, comprising: a) a	02-04-2016
20160067161	COSMETIC OR PHARMACEUTICAL COMPOSITION FOR RESISTING SKIN AGEING THROUGH AN ANTI-INFLAMMATORY ACTION - The invention relates to the use of compounds of formula (I) R—N	03-10-2016

Sergio Baroni, Villa D'Adda(bg) IT

Sergio Baroni, Villa D'Adda (bg) IT

Patent application number	Description	Published
20110288058	Methods for Preventing or Reducing Colon Carcinogenesis - The present invention is directed in part to methods of preventing or reducing colon carcinogenesis comprising administering to a patient at risk of colorectal cancer, a pharmaceutical preparation comprising disclosed chemopreventive. In another aspect, the invention is directed to methods attenuation of oxygen free radicals comprising administrating to a patient in need thereof an antioxidant effective amount of a compound represented by formula I, IIa or IIb as disclosed herein.	11-24-2011
20110288177	Methods for Preventing or Reducing Colon Carcinogenesis - The present invention is directed in part to methods of preventing or reducing colon carcinogenesis comprising administering to a patient at risk of colorectal cancer, a pharmaceutical preparation comprising a chemopreventive agent disclosed herein.	11-24-2011
20120015033	ANTISENSE COMPOSITIONS AND METHODS OF MAKING AND USING SAME - The present invention provides pharmaceutical formulations for oral administration of antisense oligonucleotides, such as antisense oligonucleotides against SMAD7. The pharmaceutical formulations can be used to treat Crohn's disease, ulcerative colitis and chronic inflammatory bowel disease.	01-19-2012
20120094948	Analogous Compounds of 6-Thioguanosine Triphosphate, their use in Medical Fields and Processes for their Preparation - The invention relates to analogous compounds of 6-thioguanosine triphosphate of general formula (I). A compound of the general formula (I); wherein the dashed bond in the sugar moiety can be either single or double and wherein R1, R2, R3, R4 or R5, equal or different between each other, have general formula -(Int)	04-19-2012
20150125523	ANTISENSE COMPOSITIONS AND METHODS OF MAKING AND USING SAME - The present invention provides pharmaceutical formulations for oral administration of antisense oligonucleotides, such as antisense oligonucleotides against SMAD7. The pharmaceutical formulations can be used to treat Crohn's disease, ulcerative colitis and chronic inflammatory bowel disease.	05-07-2015
20150232854	ANTISENSE COMPOSITIONS AND METHODS OF MAKING AND USING SAME - The present invention provides pharmaceutical formulations for oral administration of antisense oligonucleotides, such as antisense oligonucleotides against SMAD7. The pharmaceutical formulations can be used to treat Crohn's disease, ulcerative colitis and chronic inflammatory bowel disease.	08-20-2015

Sergio Baroni, Milan IT

Patent application number	Description	Published
20100034904	COMPOSITION COMPRISONG RUTIN AND POLYUNSATURATED FATTY ACID HAVING AN INHIBITORY ACTIVITY ON 5-ALPH REDUCTASE - The present invention relates to the use of selected active principles of a natural origin in substitution of extract from Boehmeria Nipononivea for regulating the trophism of hair follicles and the production of sebum on the skin and its use in alopecia, with considerable practical advantages and with respect to the safety profile.	02-11-2010

Simona Baroni, Torino IT

Patent application number	Description	Published
20100000564	HAIR DYE COMPOSITION - A hair dye composition including a first part containing an alkaline agent and a second part containing an oxidizing agent, which are mixed together immediately before use, wherein at least one of the first part and the second part contains a diazacycloheptane represented by the following general formula (1) or a salt thereof, and the pH of the mixture is 7.5 to 12;	01-07-2010